Evidence map›Paper›PMID 30888492›Full record

ArticleLung2019

Physical Inactivity in Pulmonary Sarcoidosis.

Peter S P Cho, Sharmila Vasudevan, Matthew Maddocks, Arietta Spinou, Sarah Chamberlain Mitchell, Claire Wood, Caroline J Jolley, Surinder S Birring

Open access · hybridAbstract read
In one paragraph

Article in Lung, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 3 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 3 syntheses or guidelines pooled it, 30 citations in OpenAlex.

  1. Physical activity measurements in individuals with interstitial lung disease: a systematic review and meta-analysis.European respiratory review : an official journal of the European Respiratory Society · 2023
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Potential limitations of activity tracking devices in monitoring effects of treatment for sarcoidosis.Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG · 2023
    Article
  12. Article
  13. Article
  14. Review
  15. Observational
  16. Long-Term Benefits of Tailored Exercise in Severe Sarcoidosis: A Case Report.International journal of environmental research and public health · 2020
    Article
  17. Benefit of Wearing an Activity Tracker in Sarcoidosis.Journal of personalized medicine · 2020
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Peter S P ChoCentre for Human and Applied Physiological Sciences, School of Basic and Medical Biosciences, King's College London, London, UK.ORCID 0000-0001-8689-8541
Sharmila VasudevanSchool of Medicine, King's College London, London, UK.
Matthew MaddocksCicely Saunders Institute of Palliative Care, Policy and Rehabilitation, King's College London, Denmark Hill, London, UK.
Arietta SpinouSchool of Health Sport and Bioscience, University of East London, London, UK.ORCID 0000-0002-3442-4739
Sarah Chamberlain MitchellSchool of Health and Rehabilitation, Keele University, Keele, UK.
Claire WoodDepartment of Respiratory Medicine, King's College Hospital NHS Foundation Trust, Denmark Hill, SE5 9RS, London, UK.
Caroline J JolleyCentre for Human and Applied Physiological Sciences, School of Basic and Medical Biosciences, King's College London, London, UK.
Surinder S BirringCentre for Human and Applied Physiological Sciences, School of Basic and Medical Biosciences, King's College London, London, UK. surinder.birring@nhs.net.
King's College London · GBKeele University · GBKing's College Hospital NHS Foundation Trust · GBUniversity of East London · GB

Funding

Department of Health CDF-2017-10-009
6 · The paper itself

Abstract

purposeReduced physical activity in many chronic diseases is consistently associated with increased morbidity. Little is known about physical activity in sarcoidosis. The aim of this study was to objectively assess physical activity in patients with pulmonary sarcoidosis and investigate its relationship with lung function, exercise capacity, symptom burden, and health status.

methodsPhysical activity was assessed over one week in 15 patients with pulmonary sarcoidosis and 14 age-matched healthy controls with a tri-axial accelerometer (ActivPal™) and the International Physical Activity Questionnaire (IPAQ). All participants underwent pulmonary function tests, 6-min walk test (6MWT) and completed the Fatigue Assessment Scale (FAS), Medical Research Council (MRC) Dyspnoea Scale and the King's Sarcoidosis Questionnaire (KSQ).

resultsPatients with sarcoidosis had significantly lower daily step counts than healthy controls; mean (SD) 5624 (1875) versus 10,429 (2942) steps (p < 0.01) and a trend towards fewer sit-to-stand transitions each day (p = 0.095). Only two patients (13%) self-reported undertaking vigorous physical activity (IPAQ) compared to half of healthy individuals (p < 0.01). Daily step count was significantly associated with 6MWT distance in sarcoidosis (r = 0.634, p = 0.01), but not with forced vital capacity (r = 0.290), fatigue (r = 0.041), dyspnoea (r = -0.466) or KSQ health status (r = 0.099-0.484). Time spent upright was associated with fatigue (r = -0.630, p = 0.012) and health status (KSQ Lung scores r = 0.524, p = 0.045), and there was a significant correlation between the number of sit-to-stand transitions and MRC dyspnoea score (r = -0.527, p = 0.044).

conclusionPhysical activity is significantly reduced in sarcoidosis and is associated with reduced functional exercise capacity (6MWD). Fatigue, exertional symptoms and health status were more closely associated with time spent upright and the number of bouts of physical activity, as compared to step counts. Further studies are warranted to identify the factors that determine different physical activity profiles in sarcoidosis.

Indexed as

ExerciseExercise ToleranceSedentary BehaviorAccelerometryAdultAgedCase-Control StudiesDyspneaFatigueHumansMiddle AgedSarcoidosis, PulmonaryVital CapacityWalk TestExercise capacityPhysical activitySarcoidosis

Identifiers

PMID30888492
PMCPMC6520325
OpenAlexW2925121389

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.